• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能性胃肠病不断演变的病理生理模型:对治疗的启示

Evolving pathophysiological model of functional gastrointestinal disorders: implications for treatment.

作者信息

Mayer Emeran A, Naliboff Bruce D, Chang Lin

机构信息

UCLA/CURE Neuroenteric Disease Program, Department of Medicine, Physiology and Biobehavioral Sciences, UCLA School of Medicine, Los Angeles 90073, USA.

出版信息

Eur J Surg Suppl. 2002(587):3-9.

PMID:16144195
Abstract

The physiological effects of psychological and physical stressors on gut function and brain-gut interactions are mediated by outputs of the emotional motor system in terms of autonomic, neuroendocrine, attentional, and pain modulatory responses. IBS patients with irritable bowel syndroms show an exaggerated responsiveness of this system manifesting itself in altered modulation of gastrointestinal motility and epithelial function, in alterations in the perception of visceral events, and in the associated conscious emotional responses. Animal models are being developed with high face and construct validity for functional visceral disorders that affect the gastrointestinal and urogenital tracts. These animal models suggest plausible targets for future drug development both in the periphery and in the central nervous system.

摘要

心理和生理应激源对肠道功能及脑-肠相互作用的生理影响,是通过自主神经、神经内分泌、注意力及疼痛调节反应等情绪运动系统的输出介导的。患有肠易激综合征的肠易激综合征患者表现出该系统反应过度,表现为胃肠动力和上皮功能调节改变、内脏事件感知改变以及相关的有意识情绪反应改变。正在开发具有高表面效度和结构效度的动物模型,用于研究影响胃肠道和泌尿生殖道的功能性内脏疾病。这些动物模型为未来在外周和中枢神经系统的药物开发提供了合理的靶点。

相似文献

1
Evolving pathophysiological model of functional gastrointestinal disorders: implications for treatment.功能性胃肠病不断演变的病理生理模型:对治疗的启示
Eur J Surg Suppl. 2002(587):3-9.
2
Irritable bowel syndrome: a model of the brain-gut interactions.肠易激综合征:脑-肠相互作用的一个模型
Med Sci Monit. 2004 Apr;10(4):RA55-62.
3
The brain-gut axis in irritable bowel syndrome--clinical aspects.肠易激综合征中的脑-肠轴——临床方面
Med Sci Monit. 2004 Jun;10(6):RA125-31. Epub 2004 Jun 1.
4
Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome.肠易激综合征病理生理学中消化道感觉运动功能的改变。
Best Pract Res Clin Gastroenterol. 2004 Aug;18(4):747-71. doi: 10.1016/j.bpg.2004.06.004.
5
Pharmacological treatment of irritable bowel syndrome--from concept to sales.肠易激综合征的药物治疗——从概念到销售。
Eur J Surg Suppl. 2002(587):10-5.
6
New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.肠易激综合征发病机制与病理生理学的新见解
Dig Liver Dis. 2007 Mar;39(3):201-15. doi: 10.1016/j.dld.2006.10.014. Epub 2007 Jan 30.
7
Basic pathophysiologic mechanisms in irritable bowel syndrome.
Dig Dis. 2001;19(3):212-8. doi: 10.1159/000050682.
8
[Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].[功能性肠病腹部症状发病机制的最新见解]
Recenti Prog Med. 2007 Feb;98(2):69-73.
9
Gastrointestinal pharmacology: irritable bowel syndrome.
Curr Opin Pharmacol. 2005 Dec;5(6):583-8. doi: 10.1016/j.coph.2005.06.006. Epub 2005 Sep 26.
10
[Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders].[内脏敏感性紊乱在功能性胃肠病发病机制中的作用]
Folia Med Cracov. 2004;45(1-2):33-49.

引用本文的文献

1
The Lytic Activity of Bacteriophage ZCSE9 against and Its Synergistic Effects with Kanamycin.噬菌体 ZCSE9 对 的裂解活性及其与卡那霉素的协同作用。
Viruses. 2023 Mar 31;15(4):912. doi: 10.3390/v15040912.
2
Causal Relationship between Physiological and Pathological Processes in the Brain and in the Gastrointestinal Tract: The Brain-Intestine Axis.大脑与胃肠道生理和病理过程之间的因果关系:脑-肠轴
Biophysics (Oxf). 2022;67(6):972-986. doi: 10.1134/S0006350922060197. Epub 2023 Mar 3.
3
P22 Phage Shows Promising Antibacterial Activity under Pathophysiological Conditions.
P22噬菌体在病理生理条件下显示出有前景的抗菌活性。
Arch Microbiol Immunol. 2022;6(1):81-100. doi: 10.26502/ami.93650078. Epub 2022 Feb 10.
4
Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.肠易激综合征的发病机制、实验模型与现代药物治疗:关于脑-肠轴的故事
Curr Neuropharmacol. 2016;14(8):842-856. doi: 10.2174/1570159x14666160324144154.
5
The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study.美国军队中肠易激综合征的流行病学:千年队列研究的结果
Am J Gastroenterol. 2016 Jan;111(1):93-104. doi: 10.1038/ajg.2015.386. Epub 2016 Jan 5.
6
Anti-Inflammatory Activities of a Chinese Herbal Formula IBS-20 In Vitro and In Vivo.中药配方 IBS-20 的体外和体内抗炎活性。
Evid Based Complement Alternat Med. 2012;2012:491496. doi: 10.1155/2012/491496. Epub 2012 Feb 22.
7
The role of experimental models in developing new treatments for irritable bowel syndrome.实验模型在开发肠易激综合征新疗法中的作用。
Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):43-57. doi: 10.1586/egh.10.88.
8
The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome.压力在肠易激综合征生理反应和临床症状中的作用。
Gastroenterology. 2011 Mar;140(3):761-5. doi: 10.1053/j.gastro.2011.01.032. Epub 2011 Jan 19.
9
Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.功能性胃肠病的治疗进展:肠易激综合征
Therap Adv Gastroenterol. 2009 May 1;2(3):169-181. doi: 10.1177/1756283X08103656.
10
Predictors of patient-assessed illness severity in irritable bowel syndrome.肠易激综合征患者自我评估疾病严重程度的预测因素
Am J Gastroenterol. 2008 Oct;103(10):2536-43. doi: 10.1111/j.1572-0241.2008.01997.x. Epub 2008 Jun 12.